《半日總結》恆指跌473點 科網及消費股弱 阿里挫逾5%
阿思達克 07-29 12:29
杭州市監局就低價惡性競爭等問題約談多間科網企業，市場再度憂慮科網股監管問題，港股早市下跌，恆指高開24點後掉頭向下，曾跌496點見20,126黜，半日跌473點或2.3%，報20,148點；國指跌200點或2.83%，報6,882點；恆生科技指數跌193點或4.25%，報4,358點。大市半日成交總額633.59億元，滬、深港通南下交易半日分別淨流入3,860萬及3.75億元人民幣。
科網股受壓，遭杭州市監局約談的美團(03690.HK)及餓了麼平台母公司阿里巴巴(09988.HK)各跌5.2%及5.8%，分別報178.2元及93.4元。騰訊(00700.HK)跌3.4%報309.8元，小米(01810.HK)跌4%報12.48元，京東(09618.HK)跌4.2%報234.6元。快手(01024.HK)及嗶哩嗶哩(09626.HK)各跌8.3%及7.1%。此外，京東健康(06618.HK)跌9.4%，微博(09898.HK)、商湯(00020.HK)及阿里健康(00241.HK)各跌6.1%至7%。手機相關股比亞迪電子(00285.HK)跌5.6%，電訊設備股京信通信(02342.HK)跌4.7%。
消費股下滑，百威亞太(01876.HK)績後股價回吐5.9%報22.3元，九毛九(09922.HK)及泡泡瑪特(09992.HK)各跌5.1%及6.7%，潤啤(00291.HK)、青啤(00168.HK)、呷哺呷哺(00520.HK)及頤海(01579.HK)各跌3.3%至4%。體育用品股李寧(02331.HK)跌4.6%。醫藥股信達生物(01801.HK)跌5.3%，復星醫藥(02196.HK)、藥明生物(02269.HK)、百濟神州(06160.HK)及中國中藥(00570.HK)各跌逾4%。
內房股龍湖(00960.HK)跌5%，合景泰富(01813.HK)、碧桂園(02007.HK)及萬科(02202.HK)各跌3.4%至4.1%，合景泰富向標普要求撤銷信貸評級。物管股碧服(06098.HK)及華潤萬象(01209.HK)各跌5.8%及5%。濠賭股新濠國際(00200.HK)、澳博(00880.HK)及美高梅中國(02282.HK)各跌3.6%至4.2%。
金融股方面，匯控(00005.HK)跌0.9%報49.15元，港交所(00388.HK)跌2.2%報359.6元，友邦(01299.HK)跌1.1%報79.05元。渣打(02888.HK)公布業績前股價跌2.9%報54.3元。
其他股份方面，航運股東方海外(00316.HK)及太平洋航運(02343.HK)各升3.9%及6.7%。航空股國航(00753.HK)跌4.2%，北京首都機場(00694.HK)及中國民航信息(00696.HK)各跌5.7%及6%。出口股創科(00669.HK)及敏華(01999.HK)各跌5.3%及4.2%。光伏股信義光能(00968.HK)逆升5.8%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
